09.06.2020
- US protein engineering company Codexis is collaborating with compatriot firm Alphazyme on the production and marketing of enzymes for life science applications. The companies have...
19.02.2020
- Enzymaster develops and produces products for pharmaceuticals, fine chemicals and other sectors from the initial product idea to commercial ton scale production by using...
17.05.2019
- US protein engineering company Codexis has signed a platform agreement with Novartis, granting the Swiss pharmaceutical producer a non-exclusive license to its proprietary...
25.02.2019
- Codexis appointed Laurie Heilmann as senior vice president of Business Development and Marketing. In her new role she will be responsible for developing the strategies and...
11.04.2017
- US protein engineering company Codexis has signed a second multi-year supply agreement with multinational food ingredients company Tate & Lyle to supply a proprietary enzyme. The...
23.10.2015
- US protein engineering company Codexis has completed wave 1 of the transfer of its proprietary CodeEvolver platform technology to compatriot drug maker Merck. Under the agreement...
05.08.2015
- In its second licensing agreement with a major pharmaceutical company, Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, has agreed to...
02.10.2014
- Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...
